Delivery Order SPE2DB22D2206-SPE2DB24FJC13

Award Date 7/8/24
Potential Completion Date 7/9/24
Potential Value $26K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,125.96 Firm Fixed Price Delivery Order is for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a diabetes management medication. The contract has an ultimate completion date of January 10, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,426.63 Firm Fixed Price Delivery Order covers the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a medication used for diabetes management. The contract has an ultimate completion date of October 23, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,731.39 fixed-price delivery order is for VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a pharmaceutical product, with a completion date of November 8, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,942.21 firm fixed price delivery order is for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a specialty medication. The award has an ultimate completion date of September 25, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $2,056.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a medication used for diabetes management. The contract has an ultimate completion date of November 22, 2023 and is a Firm Fixed Price arrangement. This award is not designated as a set-aside contract....
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of VICTOZA 2-PAK 18 MG/3 ML PEN 3ML. The $1,093.30 firm fixed-price delivery order has a completion date of September 11, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,700.60 Firm Fixed Price Delivery Order contract is for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a specialty medication. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,080.29 delivery order is for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a specialized medication used for diabetes management. The contract has a firm fixed price pricing type and a period of performance through November 25, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery...
This federal contract award, valued at $8,655.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a specialty diabetes medication. The award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,825.20 firm fixed-price delivery order is for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a prescription medication. The award has an ultimate completion date of June 10, 2024 and is not associated with any set-aside requirements. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FJC13
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,472.01 Firm Fixed Price delivery order is for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a medication used in the treatment of diabetes. The contract has an ultimate completion date of July 9, 2024.

AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for federal healthcare beneficiaries.

The contract award does not have a set-aside designation, indicating open competition.

Generated 5/17/25, 10:16 AM